Welcome Guest | Register / Login

Global Healthcare CMO Market: Size and Forecasts with Impact Analysis of Covid-19 (2020-2024)

Table of Contents

1. Executive Summary

2. Introduction
2.1 Contract Manufacturing: An Overview
2.1.1 Healthcare CMOs
2.1.2 Healthcare CMOs Market Segments
2.1.3 Pharmaceutical CMOs
Active Pharmaceutical Ingredients (API)
Finished Dosage Formulations (FDF)
2.1.4 Medical CMOs
2.2 Pharmaceutical Outsourcing: An Overview
2.2.1 Pharmaceutical Outsourcing Market Segments
2.3 Pharmaceutical CMOs v/s CDMOs

3. Global Market Analysis
3.1 Global Healthcare CMO Market Analysis
3.1.1 Global Healthcare CMO Market by Value
3.1.2 Global Healthcare CMO Market by Segments (Medical Devices CMO and Pharmaceutical CMO)
3.2 Global Healthcare CMO Market: Segment Analysis
3.2.1 Global Medical Device CMO Market by Value
3.2.2 Global Pharmaceutical CMO Market by Value
3.3 Global Pharmaceutical CMO Market Analysis
3.3.1 Global Pharmaceutical CMO Market by Segments (Active Pharmaceutical Ingredient, Finished Dosage Formulation and Packaging)
3.4 Global Pharmaceutical CMO Market: Segment Analysis
3.4.1 Global Active Pharmaceutical Ingredient CMO Market by Value
3.5 Global Healthcare CMO Market Regional Analysis
3.5.1 Global Healthcare CMO Market by Region (Asia Pacific and Rest of the World)

4. Regional Analysis
4.1 Asia Pacific Healthcare CMO Market Analysis
4.1.1 Asia Pacific Healthcare CMO Market by Value

5. Impact of Covid-19
5.1 Global Pharmaceutical CDMO Market Analysis
5.1.1 Global Pharmaceutical CDMO Market by Value
5.2 Surge in Contracts to CDMOs
5.3 Supply Chain Issues amidst Surge in Demand for CDMOs
5.4 Prepardeness in the Event of Supply Chain Disruption

6. Competitive Landscape
6.1 Global Healthcare CMO Market Players Financial Comparison

7. Company Profiles
7.1 Catalent Inc.
7.1.1 Business Overview
7.1.2 Financial Overview
7.1.3 Business Strategy
7.2 Recipharm
7.2.1 Business Overview
7.2.2 Financial Overview
7.2.3 Business Strategy
7.3 Aurobindo Pharma Limited
7.3.1 Business Overview
7.3.2 Financial Overview
7.3.3 Business Strategy
7.4 Boehringer Ingelheim
7.4.1 Business Overview
7.4.2 Financial Overview
7.4.3 Business Strategy

List of Tables

Table 1: Contracts placed with Pharmaceutical CDMOs; 2020
Table 2: Global Healthcare CMO Market Players Financial Comparison; 2019

List of Figures

Figure 1: Healthcare CMOs Market Segments
Figure 2: Pharmaceutical Outsourcing Market Segments
Figure 3: Value Chain of a Drug
Figure 4: Global Healthcare CMO Market by Value; 2018-2019 (US$ Billion)
Figure 5: Global Healthcare CMO Market by Value; 2020-2024 (US$ Billion)
Figure 6: Global Healthcare CMO Market by Segments; 2019
Figure 7: Global Medical Device CMO Market by Value; 2018-2019 (US$ Billion)
Figure 8: Global Medical Device CMO Market by Value; 2020-2024 (US$ Billion)
Figure 9: Global Pharmaceutical CMO Market by Value; 2018-2019 (US$ Billion)
Figure 10: Global Pharmaceutical CMO Market by Value; 2020-2024 (US$ Billion)
Figure 11: Global Pharmaceutical CMO Market by Segments; 2019 (Percentage,%)
Figure 12: Global Active Pharmaceutical Ingredient CMO Market by Value; 2018-2019 (US$ Billion)
Figure 13: Global Active Pharmaceutical Ingredient CMO Market by Value; 2020-2024 (US$ Billion)
Figure 14: Global Healthcare CMO Market by Region; 2019 (Percentage,%)
Figure 15: Asia Pacific CMO Market by Value; 2018-2019 (US$ Billion)
Figure 16: Asia Pacific CMO Market by Value; 2020-2024 (US$ Billion)
Figure 17: Global Pharmaceutical CDMO Market by Value; 2018-2019 (US$ Billion)
Figure 18: Global Pharmaceutical CDMO Market by Value; 2020-2024 (US$ Billion)
Figure 19: Catalent, Inc. Revenue; 2015-2019 (US$ Billion)
Figure 20: Catalent, Inc. Revenue by Segments; 2019
Figure 21: Recipharm Net Sales; 2015-2019 (US$ Million)
Figure 22: Recipharm Net Sales by Segments; 2019
Figure 23: Recipharm Net Sales by Region; 2019
Figure 24: Aurobindo Revenues; 2015-2019 (US$ Billion)
Figure 25: Aurobindo Revenues by Segments; 2019
Figure 26: Boehringher Ingelheim Net Sales; 2015-2019 (US$ Billion)
Figure 27: Boehringher Ingelheim Net Sales by Geography; 2019
Figure 28: Boehringher Ingelheim Net Sales by Business; 2019

Single User License: Report will be emailed in PDF format and can be accessed by a specific user. This License type allows the report to be Printed.
Corporate/Global User License: Report will be emailed in PDF format and allows all employees within the organization to access it.  This License type allows the report to be Printed.
Why http://www.marketreportsonline.com/
Published By :Daedal Research
Price
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy